Sponsors
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery
European pharma: where next?
What does Europe have to gain from an innovative, research-based pharmaceutical industry? And what challenges is the industry facing? By Brian Ager, Director General of the European Federation of Pharmaceutical Industries and Associations EFPIA.
It’s all about… Innovation
In their quest to be innovative, pharmaceutical and biotechnological companies are applying their own strategies in response to the growing demands for improvement, creative ideas, breakthrough technologies and new medicines.
The EU and you
Martin Terberger, Head of Unit, Pharmaceuticals, Directorate General, Enterprise and Industry outlines the European Commission’s view on pharma moving forward.
Great expectations
The pharmaceutical business – once the envy of fellow industries for its year-on-year surging profits – has suddenly found itself staring at a crisis.
GFC Transfection Arrays™ for High-throughput Over-expression Screening for Functional Genes in a Biological Process
Introduction
GFC Transfection Arrays are a novel screening tool to identify key functional genes in a biological pathway.
Source: www.ngpharma.eu.com© 2013 GDS Publishing Ltd. All rights reserved.